A new path to cancer therapy: developing simultaneous multiplexed gene editing technology

Scientists have developed a new gene editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the surface of lymphoma cells and activation of cytotoxic T lymphocyte.

Quelle: Sciencedaily